Health news website State News reported on Tuesday that AstraZeneca PLC has suspended a delayed hearing of a leading vaccine candidate for Kovid-19 after a suspected critical reaction from a study participant.
It quoted an AstraZeneca spokeswoman as saying that “the standard review process has begun to prevent vaccinations to allow for the review of safety data.”
The study is testing the Covid-19 vaccine being developed by researchers at AstraZeneca and the University of Oxford, in various locations, including the United Kingdom, where adverse events have been reported.
The nature of the case and when it happened were not detailed, according to State News, although the participant is expected to recover.
The suspension of the trial has affected others AstraZeneca vaccine trial – as well as clinical trials being conducted by other vaccine makers looking for signs of such reactions, the state said.
A spokeswoman for AstraZeneca said in a statement that “in large trials, the disease is likely to occur but should be reviewed independently for careful screening.” The state reported that severe reactions vary. And it can include issues that require hospitalization, life-threatening illness and death.
AstraZeneca did not immediately respond to a request for comment.
Nine major US and European vaccine developers on Tuesday pledged to uphold scientific safety and performance standards for their experimental vaccines. Coronavirus ubiquitous epidemic.
Companies, including AstraZeneca, Pfizer Inc. and GlaxoSmithKline, called it a “historic promise” after growing concerns that safety measures could lead to political pressure to hasten a vaccine.
The companies said they would “maintain the integrity of the scientific process as they work for possible global regulatory filings and approval of the first Covid-19 vaccine.”
Other signatories were Johnson & Johnson, Merck & Co., Moderna Inc., Novavax Inc., Snofi & Biontech.
